ArticleFrontiers in neurology2017

Stopping Onabotulinum Treatment after the First Two Cycles Might Not Be Justified: Results of a Real-life Monocentric Prospective Study in Chronic Migraine.

Paola Sarchielli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.